Physician profile
Seth A Riddle
NPI 1598701955
$9,972.08
in general payments reported to CMS, 2019-2025
17 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,805 · 2020: $64.44 · 2021: $212 · 2022: $545 · 2023: $4,096 · 2024: $1,124 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,471 · Food and Beverage: $841 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,471.22 |
| Food and Beverage | $840.76 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $5,041.72 | 2019-2024 | Acclarent Balloon Inflation Device, Trudi Nav Suction, Relieva Spinplus |
| Optinose US, INC. | $3,946.95 | 2019-2024 | |
| Stryker Corporation | $322.08 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $117.05 | 2020-2023 | Dupixent |
| Intersect Ent, INC. | $109.49 | 2020-2022 | |
| Depuy Synthes Sales INC. | $79.30 | 2022 | |
| Kaleo, INC. | $57.59 | 2021-2023 | Auvi-Q |
| Amgen INC. | $56.03 | 2025 | Tezspire |
| Glaxosmithkline, LLC. | $51.18 | 2022-2023 | Nucala |
| Aerin Medical INC. | $50.00 | 2020-2023 | |
| Medtronic, INC. | $38.08 | 2024-2025 | Propel |
| Astrazeneca Pharmaceuticals LP | $29.61 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $19.65 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Grifols USA, LLC | $16.46 | 2023 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $13.89 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $13.06 | 2021 | |
| Itamar Medical INC | $9.94 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Riddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.